246 related articles for article (PubMed ID: 21396106)
1. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.
Winkler C; Atochina-Vasserman EN; Holz O; Beers MF; Erpenbeck VJ; Krug N; Roepcke S; Lauer G; Elmlinger M; Hohlfeld JM
Respir Res; 2011 Mar; 12(1):29. PubMed ID: 21396106
[TBL] [Abstract][Full Text] [Related]
2. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.
Kobayashi H; Kanoh S; Motoyoshi K
Biomarkers; 2008 Jun; 13(4):385-92. PubMed ID: 18595202
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
4. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
[TBL] [Abstract][Full Text] [Related]
5. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease.
Moré JM; Voelker DR; Silveira LJ; Edwards MG; Chan ED; Bowler RP
BMC Pulm Med; 2010 Oct; 10():53. PubMed ID: 20973980
[TBL] [Abstract][Full Text] [Related]
6. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.
Lomas DA; Silverman EK; Edwards LD; Locantore NW; Miller BE; Horstman DH; Tal-Singer R;
Eur Respir J; 2009 Jul; 34(1):95-102. PubMed ID: 19164344
[TBL] [Abstract][Full Text] [Related]
7. Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study.
Sims MW; Tal-Singer RM; Kierstein S; Musani AI; Beers MF; Panettieri RA; Haczku A
Respir Res; 2008 Jan; 9(1):13. PubMed ID: 18226251
[TBL] [Abstract][Full Text] [Related]
8. Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease.
Ito E; Oka R; Ishii T; Korekane H; Kurimoto A; Kizuka Y; Kitazume S; Ariki S; Takahashi M; Kuroki Y; Kida K; Taniguchi N
J Proteomics; 2015 Sep; 127(Pt B):386-94. PubMed ID: 26206179
[TBL] [Abstract][Full Text] [Related]
9. Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease.
Shakoori TA; Sin DD; Ghafoor F; Bashir S; Bokhari SN
Dis Markers; 2009; 27(6):287-94. PubMed ID: 20075511
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPD.
Duvoix A; Miranda E; Perez J; Sorensen GL; Holmskov U; Trapnell BC; Madsen J; Clark HW; Edwards LD; Miller BE; Tal-Singer RM; Lomas DA
COPD; 2011 Apr; 8(2):79-95. PubMed ID: 21495836
[TBL] [Abstract][Full Text] [Related]
11. Integrating lung and plasma expression of pneumo-proteins in developing biomarkers in COPD: a case study of surfactant protein D.
Tkacova R; McWilliams A; Lam S; Sin DD
Med Sci Monit; 2010 Nov; 16(11):CR540-4. PubMed ID: 20980958
[TBL] [Abstract][Full Text] [Related]
12. Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction.
Ilumets H; Mazur W; Toljamo T; Louhelainen N; Nieminen P; Kobayashi H; Ishikawa N; Kinnula VL
BMC Pulm Med; 2011 Apr; 11():19. PubMed ID: 21504569
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population.
Ou CY; Chen CZ; Hsiue TR; Lin SH; Wang JY
Respirology; 2015 Feb; 20(2):296-303. PubMed ID: 25376584
[TBL] [Abstract][Full Text] [Related]
14. Surfactant protein A expression and distribution in human lung samples from smokers with or without chronic obstructive pulmonary disease in China.
Liu Z; Chen S; Xu Y; Liu X; Xiong P; Fu Y
Medicine (Baltimore); 2020 Feb; 99(7):e19118. PubMed ID: 32049827
[TBL] [Abstract][Full Text] [Related]
15. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease.
Ju CR; Liu W; Chen RC
Dis Markers; 2012; 32(5):281-7. PubMed ID: 22674408
[TBL] [Abstract][Full Text] [Related]
16. Increased serum SP-D in identification of high-risk smokers at high risk of COPD.
Dalgård C; Wang F; Titlestad IL; Kyvik KO; Vestbo J; Sorensen GL
Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L1005-L1010. PubMed ID: 33759571
[TBL] [Abstract][Full Text] [Related]
17. Serum Surfactant Protein D is a Potential Biomarker for Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis.
Wang H; Li F; Huang H; Wu F; Chen L; Zhang D; Zhang T; Wan Y
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850711
[TBL] [Abstract][Full Text] [Related]
18. Annexin A1 is elevated in patients with COPD and affects lung fibroblast function.
Lai T; Li Y; Mai Z; Wen X; Lv Y; Xie Z; Lv Q; Chen M; Wu D; Wu B
Int J Chron Obstruct Pulmon Dis; 2018; 13():473-486. PubMed ID: 29440885
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
de Moraes MR; da Costa AC; Corrêa Kde S; Junqueira-Kipnis AP; Rabahi MF
Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
[TBL] [Abstract][Full Text] [Related]
20. Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers.
Papaioannou AI; Loukides S; Minas M; Kontogianni K; Bakakos P; Gourgoulianis KI; Alchanatis M; Papiris S; Kostikas K
Respir Res; 2011 May; 12(1):67. PubMed ID: 21600044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
